Bunge Global S.A.
NYSE:BGAgricultural Farm Products
-$3.65 today
- Market cap
- $17.91B
- Beta
- 0.62
- P/E (TTM)
- 31.8
- EPS (TTM)
- $3.54
- Dividend yield
- 2.51%
Volume 1.49M
Average 1.70M
BG Deferred Revenue (Non-current)
Payments received for goods or services the company will deliver after more than one year.
Bunge Global S.A.NYSE: BG
Deferred Revenue (Non-current) · Q2 FY2026 · quarter ended Jun 2026
Deferred revenue (non-current) remains negative
Q2 FY2026 deferred revenue (non-current) was $0, compared with $0 a year earlier.
Context
- Deferred revenue (non-current) amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Deferred revenue (non-current) increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue (Non-current) history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Revenue (Non-current) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Deferred Revenue (Non-current) vs competitors
How BG compares with its peers on the latest reported figures
- BG's Jun 2026 deferred revenue (non-current) of $0 is the highest of the 6 companies compared; the peer median is $0.
- Deferred revenue (non-current) amounts to 0.0% of total assets for BG, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Oct 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Feb 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding BG) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for BG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 902M | 1.1B | 2.6B | 3.31B | 1.14B |
| Short-term Investments | 520M | 119M | 105M | 484M | 1.07B |
| Net Receivables | 2.51B | 3.3B | 3.02B | 2.74B | 4.82B |
| Inventory | 8.43B | 8.41B | 7.11B | 6.49B | 13.65B |
| Other Current Assets | 3.16B | 2.84B | 2.39B | 2.32B | 2.63B |
| Total Current Assets | 16.46B | 16.76B | 16.35B | 15.96B | 24.39B |
| Property, Plant & Equipment (Net) | 4.41B | 4.64B | 5.47B | 6.19B | 13.36B |
| Goodwill | 484M | 470M | 489M | 453M | 3.14B |
| Intangible Assets | 431M | 360M | 398M | 321M | 309M |
| Long-term Investments | 960M | 1.18B | 1.42B | 953M | 1.87B |
| Tax Assets | 550M | 712M | 773M | 645M | 890M |
| Other Non-current Assets | 523M | 464M | 473M | 383M | 567M |
| Total Non-current Assets | 7.36B | 7.82B | 9.02B | 8.94B | 20.14B |
| Total Assets | 23.82B | 24.58B | 25.37B | 24.9B | 44.53B |
| Account Payables | 4.25B | 4.39B | 3.66B | 2.78B | 4.88B |
| Short-term Debt | 1.18B | 1.39B | 802M | 1.54B | 5.43B |
| Tax Payables | 168M | 156M | 238M | 80M | 0 |
| Deferred Revenue | 437M | 601M | 463M | 501M | 814M |
| Other Current Liabilities | 2.25B | 1.89B | 1.25B | 1.32B | 1.88B |
| Total Current Liabilities | 9.32B | 9.6B | 7.69B | 7.44B | 15.13B |
| Long-term Debt | 4.79B | 3.26B | 4.08B | 4.69B | 8.83B |
| Deferred Tax Liabilities | 338M | 365M | 400M | 379M | 988M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 658M | 849M | 824M | 847M | 1.06B |
| Total Non-current Liabilities | 6.29B | 5.02B | 5.87B | 6.52B | 11.98B |
| Total Liabilities | 15.61B | 14.62B | 13.56B | 13.95B | 27.11B |
| Common Stock | 1M | 1M | 1M | 1M | 2M |
| Retained Earnings | 8.98B | 10.22B | 12.08B | 12.84B | 13.15B |
| Accumulated OCI | (6.47B) | (6.37B) | (6.05B) | (6.7B) | (6.08B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 537M | 736M | 964M | 1.04B | 1.52B |
| Total Equity | 8.21B | 9.96B | 11.82B | 10.95B | 17.42B |
| Total Debt | 6.82B | 5.62B | 5.76B | 7.12B | 15.86B |
| Net Debt | 5.92B | 4.52B | 3.15B | 3.81B | 14.72B |
Bunge Global S.A.
NYSE:BG
Intrinsic Alpha fair value
Locked
Current Price
$93.19
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.